Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard M Anthony

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|December 19, 2019
Towards standardisation: comparison of five whole genome sequencing (WGS) analysis pipelines for detection of epidemiologically linked tuberculosis casesRana Jajou, Thomas A Kohl, Timothy Walker, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 11, 2020
Delamanid Resistance: Update and Clinical ManagementThi Van Anh Nguyen, Richard M Anthony, Thi Thu Huyen Cao, et al.
Scientific Reports|March 29, 2025
Phylodynamic assessment of SNP distances from whole genome sequencing for determining Mycobacterium tuberculosis transmissionBastiaan R Van der Roest, Martin C J Bootsma, Egil A J Fischer, et al.
Plos One|June 27, 2015
Cytokine Kinetics in the First Week of Tuberculosis Therapy as a Tool to Confirm a Clinical Diagnosis and Guide TherapyAlice L den Hertog, María Montero-Martín, Rachel L Saunders, et al.
Plos One|January 13, 2018
Variability and cost implications of three generations of the Roche LightCycler® 480Maria Dullaert-de Boer, Onno W Akkerman, Marloes Vermeer, et al.
Plos One|February 10, 2018
Correction: Variability and cost implications of three generations of the Roche LightCycler® 480Maria Dullaert-de Boer, Onno W Akkerman, Marloes Vermeer, et al.
The Journal of Infectious Diseases|February 11, 2025
Azithromycin as Host-Directed Therapy for Pulmonary Tuberculosis: A Randomized Pilot TrialBart G J Dekkers, Huib A M Kerstjens, Helene W Breisnes, et al.
Antimicrobial Agents and Chemotherapy|November 22, 2021
Clinical Relevance of Rifampicin-Moxifloxacin Interaction in Isoniazid-Resistant/Intolerant Tuberculosis PatientsVanessa B Vogensen, Mathieu S Bolhuis, Marieke G G Sturkenboom, et al.
The European Respiratory Journal|July 11, 2024
A composite reference standard is needed for bedaquiline antimicrobial susceptibility testing for <i>Mycobacterium tuberculosis</i> complexClaudio U Köser, Paolo Miotto, Nabila Ismail, et al.
Memorias Do Instituto Oswaldo Cruz|June 8, 2017
Detection of tuberculosis drug resistance: a comparison by Mycobacterium tuberculosis MLPA assay versus Genotype®MTBDRplusPaula Fernanda Gonçalves Dos Santos, Elis Regina Dalla Costa, Daniela M Ramalho, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|December 19, 2019
Towards standardisation: comparison of five whole genome sequencing (WGS) analysis pipelines for detection of epidemiologically linked tuberculosis casesRana Jajou, Thomas A Kohl, Timothy Walker, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 11, 2020
Delamanid Resistance: Update and Clinical ManagementThi Van Anh Nguyen, Richard M Anthony, Thi Thu Huyen Cao, et al.
Scientific Reports|March 29, 2025
Phylodynamic assessment of SNP distances from whole genome sequencing for determining Mycobacterium tuberculosis transmissionBastiaan R Van der Roest, Martin C J Bootsma, Egil A J Fischer, et al.
Plos One|June 27, 2015
Cytokine Kinetics in the First Week of Tuberculosis Therapy as a Tool to Confirm a Clinical Diagnosis and Guide TherapyAlice L den Hertog, María Montero-Martín, Rachel L Saunders, et al.
Plos One|January 13, 2018
Variability and cost implications of three generations of the Roche LightCycler® 480Maria Dullaert-de Boer, Onno W Akkerman, Marloes Vermeer, et al.
Plos One|February 10, 2018
Correction: Variability and cost implications of three generations of the Roche LightCycler® 480Maria Dullaert-de Boer, Onno W Akkerman, Marloes Vermeer, et al.
The Journal of Infectious Diseases|February 11, 2025
Azithromycin as Host-Directed Therapy for Pulmonary Tuberculosis: A Randomized Pilot TrialBart G J Dekkers, Huib A M Kerstjens, Helene W Breisnes, et al.
Antimicrobial Agents and Chemotherapy|November 22, 2021
Clinical Relevance of Rifampicin-Moxifloxacin Interaction in Isoniazid-Resistant/Intolerant Tuberculosis PatientsVanessa B Vogensen, Mathieu S Bolhuis, Marieke G G Sturkenboom, et al.
The European Respiratory Journal|July 11, 2024
A composite reference standard is needed for bedaquiline antimicrobial susceptibility testing for <i>Mycobacterium tuberculosis</i> complexClaudio U Köser, Paolo Miotto, Nabila Ismail, et al.
Memorias Do Instituto Oswaldo Cruz|June 8, 2017
Detection of tuberculosis drug resistance: a comparison by Mycobacterium tuberculosis MLPA assay versus Genotype®MTBDRplusPaula Fernanda Gonçalves Dos Santos, Elis Regina Dalla Costa, Daniela M Ramalho, et al.
Pageof 5